94 related articles for article (PubMed ID: 27556859)
1. A novel molecular and clinical staging model to predict survival for patients with esophageal squamous cell carcinoma.
Wang W; Wang Z; Zhao J; Wei M; Zhu X; He Q; Ling T; Chen X; Cao Z; Zhang Y; Liu L; Shi M
Oncotarget; 2016 Sep; 7(39):63526-63536. PubMed ID: 27556859
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.
Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS
Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674
[TBL] [Abstract][Full Text] [Related]
3. Protein-coding genes combined with long noncoding RNA as a novel transcriptome molecular staging model to predict the survival of patients with esophageal squamous cell carcinoma.
Guo JC; Wu Y; Chen Y; Pan F; Wu ZY; Zhang JS; Wu JY; Xu XE; Zhao JM; Li EM; Zhao Y; Xu LY
Cancer Commun (Lond); 2018 Apr; 38(1):4. PubMed ID: 29784063
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.
Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y
Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390
[TBL] [Abstract][Full Text] [Related]
5. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
[TBL] [Abstract][Full Text] [Related]
6. A three-protein signature and clinical outcome in esophageal squamous cell carcinoma.
Cao HH; Zhang SY; Shen JH; Wu ZY; Wu JY; Wang SH; Li EM; Xu LY
Oncotarget; 2015 Mar; 6(7):5435-48. PubMed ID: 25605255
[TBL] [Abstract][Full Text] [Related]
7. Identification of genomic biomarkers associated with the clinicopathological parameters and prognosis of esophageal squamous cell carcinoma.
Shi ZZ; Shang L; Jiang YY; Shi F; Xu X; Wang MR; Hao JJ
Cancer Biomark; 2015; 15(6):755-61. PubMed ID: 26406417
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and outcome for patients with esophageal squamous cell carcinoma underwent surgical resection alone: evaluation of the seventh edition of the American Joint Committee on Cancer staging system for esophageal squamous cell carcinoma.
Chen SB; Weng HR; Wang G; Yang JS; Yang WP; Liu DT; Chen YP; Zhang H
J Thorac Oncol; 2013 Apr; 8(4):495-501. PubMed ID: 23446203
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-regulated gene expression and prognosis in loco-regional gastroesophageal cancer.
Winther M; Alsner J; Tramm T; Nordsmark M
Acta Oncol; 2013 Oct; 52(7):1327-35. PubMed ID: 23957682
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.
Hoshimoto S; Takeuchi H; Ono S; Sim MS; Huynh JL; Huang SK; Marzese DM; Kitagawa Y; Hoon DS
J Thorac Oncol; 2015 Mar; 10(3):509-17. PubMed ID: 25514805
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
12. DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma.
Yuen HF; Chan YP; Law S; Srivastava G; El-Tanani M; Mak TW; Chan KW
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3593-602. PubMed ID: 19064576
[TBL] [Abstract][Full Text] [Related]
13. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.
Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH
Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143
[TBL] [Abstract][Full Text] [Related]
14. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
[TBL] [Abstract][Full Text] [Related]
15. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
[TBL] [Abstract][Full Text] [Related]
16. MiRNA expression profile reveals a prognostic signature for esophageal squamous cell carcinoma.
Chen Z; Li J; Tian L; Zhou C; Gao Y; Zhou F; Shi S; Feng X; Sun N; Yao R; Shao K; Li N; Qiu B; Tan F; He J
Cancer Lett; 2014 Aug; 350(1-2):34-42. PubMed ID: 24769072
[TBL] [Abstract][Full Text] [Related]
17. The impact of tumor cell differentiation on survival of patients with resectable esophageal squamous cell carcinomas.
Hou X; Gu YK; Liu XW; Fu JH; Wang X; Zhang LJ; Luo RZ; Lin P; Yang HX
Ann Surg Oncol; 2015 Mar; 22(3):1008-14. PubMed ID: 25201504
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors.
Wang LS; Chow KC; Chi KH; Liu CC; Li WY; Chiu JH; Huang MH
Am J Gastroenterol; 1999 Jul; 94(7):1933-40. PubMed ID: 10406262
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases.
J Am Coll Surg; 2001 Jun; 192(6):708-18. PubMed ID: 11400964
[TBL] [Abstract][Full Text] [Related]
20. Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients.
Tan HZ; Wu ZY; Wu JY; Long L; Jiao JW; Peng YH; Xu YW; Li SS; Wang W; Zhang JJ; Li EM; Xu LY
BMC Cancer; 2016 Jul; 16():560. PubMed ID: 27472962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
